These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11856074)

  • 1. Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?
    Hirsch DP; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2002 Jan; 16(1):17-26. PubMed ID: 11856074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.
    Zhang Q; Lehmann A; Rigda R; Dent J; Holloway RH
    Gut; 2002 Jan; 50(1):19-24. PubMed ID: 11772961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease.
    van Herwaarden MA; Samsom M; Rydholm H; Smout AJ
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
    Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R
    Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.
    Lidums I; Checklin H; Mittal RK; Holloway RH
    Gut; 1998 Jul; 43(1):12-6. PubMed ID: 9771399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of non-selective gamma-aminobutyric acid receptor stimulation on motor function of the lower oesophageal sphincter and gastro-oesophageal reflux in healthy human subjects.
    Cantù P; Carmagnola S; Savojardo D; Allocca M; Penagini R
    Aliment Pharmacol Ther; 2003 Oct; 18(7):699-704. PubMed ID: 14510743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects.
    Lidums I; Lehmann A; Checklin H; Dent J; Holloway RH
    Gastroenterology; 2000 Jan; 118(1):7-13. PubMed ID: 10611148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying the antireflux action of fundoplication.
    Ireland AC; Holloway RH; Toouli J; Dent J
    Gut; 1993 Mar; 34(3):303-8. PubMed ID: 8472975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.
    Boulant J; Mathieu S; D'Amato M; Abergel A; Dapoigny M; Bommelaer G
    Gut; 1997 May; 40(5):575-81. PubMed ID: 9203932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux disease and baclofen: is there a light at the end of the tunnel?
    Wise J; Conklin JL
    Curr Gastroenterol Rep; 2004 Jun; 6(3):213-9. PubMed ID: 15128488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of gastro-oesophageal reflux disease through control of transient lower oesophageal sphincter relaxations--feasibility, practicality and possibilities.
    Holloway RH
    Dig Liver Dis; 2000 Apr; 32(3):183-7. PubMed ID: 10975765
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease.
    Trudgill NJ; Hussain FN; Moustafa M; Ajjan R; D'Amato M; Riley SA
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1357-64. PubMed ID: 11552906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of gastro-oesophageal reflux disease.
    De Giorgi F; Palmiero M; Esposito I; Mosca F; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog.
    Lehmann A; Hansson-Brändén L; Kärrberg L
    Eur J Pharmacol; 2000 Sep; 403(1-2):163-7. PubMed ID: 10969158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the hiatus hernia in gastro-oesophageal reflux disease.
    Gordon C; Kang JY; Neild PJ; Maxwell JD
    Aliment Pharmacol Ther; 2004 Oct; 20(7):719-32. PubMed ID: 15379832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of belching by the lower oesophageal sphincter.
    Wyman JB; Dent J; Heddle R; Dodds WJ; Toouli J; Downton J
    Gut; 1990 Jun; 31(6):639-46. PubMed ID: 2379867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
    Tonini M; De Giorgio R; De Ponti F
    Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive competence of the lower oesophageal sphincter after Nissen fundoplication: evaluation by three-dimensional computerised imaging.
    Zaninotto G; Costantini M; Anselmino M; Boccù C; Bagolin F; Polo R; Ancona E
    Eur J Surg; 1995 Apr; 161(4):241-6. PubMed ID: 7612765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethiopathogenesis of gastroesophageal reflux disease].
    Lukás K; Marecek P
    Cas Lek Cesk; 2000 Aug; 139(15):455-9. PubMed ID: 22666924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxations triggered by gastric distension.
    Boeckxstaens GE; Hirsch DP; Fakhry N; Holloway RH; D'Amato M; Tytgat GN
    Am J Gastroenterol; 1998 Oct; 93(10):1823-8. PubMed ID: 9772038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.